ESPR
ESPR
NASDAQ · Pharmaceuticals

Esperion Therapeutics Inc

$3.14
+0.00 (+0.00%)
As of May 9, 9:39 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 11 79%
Hold 2 14%
Sell 1 7%
Price Target
Analyst Price Target +502.2% upside
Low Target $12.50
Average Target $18.91
High Target $21.23
Current Price $3.14
Current
$3.14
Target
$18.91
$12.50 $18.91 avg $21.23
Scenario Analysis
Bear Case
$12.50
298.1%
Low target
Base Case
$18.91
+502.2%
Avg target
Bull Case
$21.23
+576.1%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$4.18
-24.8% from high
52-Week Low
$0.69
+353.4% from low
Target vs 52W High
$18.91
+352.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%